BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8730423)

  • 1. Intracellular calcium signalling and vascular reactivity in Bartter's syndrome.
    Calò L; D'Angelo A; Cantaro S; Rizzolo M; Favaro S; Antonello A; Borsatti A
    Nephron; 1996; 72(4):570-3. PubMed ID: 8730423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resting and stimulated cytosolic free calcium levels in neutrophils from patients with Bartter's syndrome.
    Di Virgilio F; Calò L; Cantaro S; Favaro S; Piccoli A; Borsatti A
    Clin Sci (Lond); 1987 Apr; 72(4):483-8. PubMed ID: 3829597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelium-derived vasoactive substances in Bartter's syndrome.
    Calò L; Cantaro S; Calabrò A; Piarulli F; Rizzolo M; Favaro S; Antonello A; Crepaldi G; Borsatti A
    Angiology; 1995 Oct; 46(10):905-13. PubMed ID: 7486211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rebamipide suppresses formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils.
    Nagano C; Azuma A; Ishiyama H; Sekiguchi K; Imagawa K; Kikuchi M
    J Pharmacol Exp Ther; 2001 Apr; 297(1):388-94. PubMed ID: 11259567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in Ca2+ signal transduction in critically ill surgical patients.
    Burke PA; Canning CM; Chartier S; Lazo S; Daley J; Forse RA; Ritz J
    Surgery; 1994 Aug; 116(2):378-86; discussion 386-7. PubMed ID: 8048003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased urinary NO2-/NO3- and cyclic guanosine monophosphate levels in patients with Bartter's syndrome: relationship to vascular reactivity.
    Caló L; D'Angelo A; Cantaro S; Bordin MC; Favaro S; Antonello A; Borsatti A
    Am J Kidney Dis; 1996 Jun; 27(6):784-9. PubMed ID: 8651241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superoxide anion production and phospholipase D-mediated generation of diacylglycerol are subnormal after N-formyl-methionyl-leucyl-phenylalanine stimulation of polymorphonuclear granulocytes in polycythemia vera.
    Samuelsson J; Hansson A; Rosendahl K; Palmblad J
    J Lab Clin Med; 1993 Feb; 121(2):310-9. PubMed ID: 8381848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotactic peptide activation of human neutrophils and HL-60 cells. Pertussis toxin reveals correlation between inositol trisphosphate generation, calcium ion transients, and cellular activation.
    Krause KH; Schlegel W; Wollheim CB; Andersson T; Waldvogel FA; Lew PD
    J Clin Invest; 1985 Oct; 76(4):1348-54. PubMed ID: 3877077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal transduction in N-formyl-methionyl-leucyl-phenylalanine and concanavalin A stimulated human neutrophils: superoxide production without a rise in intracellular free calcium.
    Liang SL; Woodlock TJ; Whitin JC; Lichtman MA; Segel GB
    J Cell Physiol; 1990 Nov; 145(2):295-302. PubMed ID: 2174064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased endothelial nitric oxide synthase mRNA level in Bartter's and Gitelman's syndrome. Relationship to vascular reactivity.
    Calò L; Davis PA; Milani M; Cantaro S; Antonello A; Favaro S; D'Angelo A
    Clin Nephrol; 1999 Jan; 51(1):12-7. PubMed ID: 9988141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between activating mutations of calcium-sensing receptor and Bartter's syndrome.
    Watanabe S; Fukumoto S; Chang H; Takeuchi Y; Hasegawa Y; Okazaki R; Chikatsu N; Fujita T
    Lancet; 2002 Aug; 360(9334):692-4. PubMed ID: 12241879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress-related factors in Bartter's and Gitelman's syndromes: relevance for angiotensin II signalling.
    Calò LA; Pagnin E; Davis PA; Sartori M; Semplicini A
    Nephrol Dial Transplant; 2003 Aug; 18(8):1518-25. PubMed ID: 12897089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desensitization of formyl peptide receptors is abolished in calcium ionophore-primed neutrophils: an association of the ligand-receptor complex to the cytoskeleton is not required for a rapid termination of the NADPH-oxidase response.
    Liu L; Harbecke O; Elwing H; Follin P; Karlsson A; Dahlgren C
    J Immunol; 1998 Mar; 160(5):2463-8. PubMed ID: 9498791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inositol 1,4,5-triphosphate-mediated shuttling between intracellular stores and the cytosol contributes to the sustained elevation in cytosolic calcium in FMLP-activated human neutrophils.
    Anderson R; Steel HC; Tintinger GR
    Biochem Pharmacol; 2005 Jun; 69(11):1567-75. PubMed ID: 15896336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of vascular tone in the syndromes of Bartter and Gitelman.
    Calò L; Davis PA; Semplicini A
    Crit Rev Clin Lab Sci; 2000 Dec; 37(6):503-22. PubMed ID: 11192330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
    Kew RR; Grimaldi CM; Furie MB; Fleit HB
    J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional interpretation of the kidney juxtaglomerular apparatus using renin immunohistochemistry in Bartter's, pseudo-Bartter's and Conn's syndromes.
    Lertprasertsuke N; Kakudo K; Osamura Y; Nomoto Y; Sakai H; Watanabe K
    Tokai J Exp Clin Med; 1990 Jul; 15(4):317-26. PubMed ID: 2130539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chondrocalcinosis is a feature of Gitelman's variant of Bartter's syndrome. A new look at the hypomagnesemia associated with calcium pyrophosphate dihydrate crystal deposition disease.
    Punzi L; Calò L; Schiavon F; Pianon M; Rosada M; Todesco S
    Rev Rhum Engl Ed; 1998 Oct; 65(10):571-4. PubMed ID: 9809361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superoxide responses to formyl-methionyl-leucyl-phenylalanine in primed neutrophils. Role of intracellular and extracellular calcium.
    Walker BA; Hagenlocker BE; Ward PA
    J Immunol; 1991 May; 146(9):3124-31. PubMed ID: 1849943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing regulator of G protein signaling-2 (RGS-2) increases angiotensin II signaling: insights into hypertension from findings in Bartter's/Gitelman's syndromes.
    Calò LA; Pagnin E; Ceolotto G; Davis PA; Schiavo S; Papparella I; Semplicini A; Pessina AC
    J Hypertens; 2008 May; 26(5):938-45. PubMed ID: 18398336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.